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Abstract
Background: We recently reported about the derivation of a diagnostic probability function for acute coronary
syndrome (ACS). The present study aims to validate the probability function as a rule-out criterion in a new sample
of patients.
Methods: 186 patients presenting with chest pain and/or dyspnea at one of the three participating hospitals’
emergency rooms in Switzerland were included in the study. In these patients, information on a set of pre-specified
variables was collected and a predicted probability of ACS was calculated for each patient. Approximately two
weeks after the initial visit in the emergency room, patients were contacted by phone to assess whether a diagnosis
of ACS was established.
Results: Of the 186 patients included in the study, 31 (17%) had an acute coronary syndrome. A risk probability for
ACS below 2% was considered a rule-out criterion for ACS, leading to a sensitivity of 87% and a specificity of 17%
of the rule. The characteristics of the study patients were compared to the cases from which the probability
function was derived, and considerable deviations were found in some of the variables.
Conclusions: The proposed probability function, with a 2% cut-off for ruling out ACS works quite well if the patient
data lie within the ranges of values of the original vignettes. If the observations deviate too much from these
ranges, the predicted probabilities for ACS should be seen with caution.
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Background
The swift and correct diagnosis about the presence/ab-
sence of acute coronary syndrome (ACS) in patients
with chest pain and/or dyspnea is a major diagnostic
challenge. Chest pain accounts for 2-5% of all admis-
sions to the emergency room [1]. ACS is present in
about 15-30% of the admitted patients and is the major
concern for both doctors and patients [1]. Recently we
reported on the derivation of a diagnostic probability
function to calculate the probability of an ACS in pa-
tients with acute onset of chest pain and/or dyspnea
after a first examination, including electrocardiography
(ECG) and measurement of troponin [2].
The diagnostic probability function has been derived
with an innovative method by garnering tacit experts’
knowledge. To this end 80 hypothetical cases, most of
them with a presumably low probability of ACS, were
specified and sent to 32 experts. All hypothetical cases
described patients with acute onset of chest pain and/or
dyspnea, with regard to other relevant diagnostic indica-
tors (e.g. duration of symptoms, quality of chest pain,
risk factors) and each case was different. The experts
were requested to estimate for each case the probability
for the presence of ACS. The medians of the experts’
probabilities were translated into a diagnostic probability
function, details of the derivation process can be found
elsewhere [2]. The final prediction model is based on
shrinked regression coefficients in order to reduce the
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Before applying such a probability function in daily
practice its discriminative ability and calibration should
be evaluated in a set of true patients with acute onset of
chest pain and/or dyspnea. The aim of this study was to
assess the diagnostic performance of the risk prediction
rule applied to patients in an emergency room setting.
Methods
The ethics committees of Zurich and St. Gallen approved
the study protocol, and we obtained informed consent
from all participants.
Recruitment of patients
Senior physicians of the emergency rooms from the Univer-
sity Hospital Zurich, Waid-City-Hospital Zurich and the
Cantonal Hospital in St. Gallen were asked to recruit pa-
tients and they declared their willingness to enroll patients
in this validation study.
Eligible were patients older than 18 years with the
chief complaint of acute onset of chest pain and/or dys-
pnea attending the emergency room and in which an
ECG was recorded and blood drawn for measurement of
troponin levels. Only patients were included proclaiming
their willingness to answer questions about their health
status two weeks after the visit in the emergency room
by telephone interview. Patients in need for urgent pro-
cedures because of hemodynamic instability were not
included.
Data collection
All patients admitted to the emergency room that were
potentially eligible for the study were asked to partici-
pate. Study-participation did not delay urgent diagnostic
testing or treatment and had no influence on diagnostic
and/or treatment decisions. After obtaining informed
consent the emergency physician collected information
from medical history, performed a physical exam, re-
corded an ECG and ordered blood tests. All information
was recorded about the particulars of the episode (e.g.,
time since onset of symptoms, duration of symptoms,
type of symptoms), associated symptoms during or in
days prior to the episode (e.g. nausea, dizziness, fever),
possible prompters of the episode (e.g., physical exertion,
unusual emotional stress, cocaine use), risk for ACS (e.g.,
age, smoking, history of hypertension), physical examin-
ation (e.g., heart rate, blood pressure, chest pain aggrava-
tion by pressure on chest), findings in ECG (e.g., Q-waves,
maximum or ST-elevation/depression, hyperacute T-wave)
and enzyme levels (troponin). The data were entered in a
prepared paper-form questionnaire (shown in Additional
file 1) and then transferred into a FileMaker Database
(FileMaker Inc., 5201 Patrick Henry Drive, Santa Clara,
CA 95054).
Other diagnostic procedures and the decision to initi-
ate treatment or referral of the patient to the intensive
care unit or catheter lab were left to the discretion of
the treating physician. During the consultation in the
emergency room the probabilities of an acute coronary
syndrome were not computed to avoid any influence of
a probability estimate on the further management of the
patient. From all patients hospitalized in the hospital of
attendance or referred to another hospital information
about the course of the illness was collected, in particu-
lar, whether ACS was diagnosed by the treating phys-
ician or not. Patients who were sent home after ruling
out ACS in the emergency room were contacted again
between 10 and 14 days after the consultation in the
emergency room by a research assistant by phone. The
patients were asked whether they had visited a physician
or an emergency room or had been hospitalized within
the last two weeks with further episodes of chest pain
and/or dyspnea since discharge from the emergency room.
In case of uncertainty about the presence of an ACS the
family physician was contacted. In patients without ACS
no further information about the underlying illness caus-
ing chest pain or dyspnea were collected.
Reference standard
Myocardial infarction and acute coronary syndrome
was defined according to the recommendations from
the European Society for Cardiology and the American
Heart Association [3,4].The definitions for an acute
myocardial syndrome included the detection of rise
and/or fall of cardiac biomarkers with at least one value
above the 99th percentile of the upper reference limit
together with evidence of myocardial ischemia with at
least one of the following: symptoms of ischemia, ECG
changes indicative of new ischemia (new ST-T changes
or left bundle branch block), development of patho-
logical Q waves in the ECG, imaging evidence of new
loss of viable myocardium or new abnormality. Acute
myocardial ischemia was defined as a new ST elevation
at the J-point into contiguous leads with the cut-off
point ≥0.2 mV in men or ≥0.15 mV in women in leads
V2-3 and/or ≥0.1 mV in other leads. Unstable angina/
non-ST-elevated myocardial infarciation (NSTEMI) was
defined as constitutes a clinical syndrome with electrocar-
diogram (ECG) ST-segment depression or prominent
T-wave inversion and/or positive biomarkers of necrosis
(e.g., troponin) in the absence of ST-segment elevation
and in an appropriate clinical setting (chest discomfort or
angina equivalent).
The probabilities of ACS were calculated following the
published prediction rule, only after all patient data, in-
cluding information on presence or absence of ACS had
been collected.
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Analysis of data
The characteristics of the participating patients are sum-
marized with medians and inter-quartile ranges for the
continuous variables, and with percentages for the binary
variables. The published risk prediction model is based on
43 variables and some of the original variables measured
in the patients needed a transformation according to the
procedure described in the derivation study [2]. The vari-
ables time since onset of symptoms (hours) and duration
of symptoms (minutes) were log-transformed and squared.
The number of cigarettes smoked per day in the days prior
to the episode, the number of pack years reduced by 10,
the age, the heart rate and the body mass index were
squared. The mean blood pressure was calculated as arith-
metic mean between systolic and diastolic blood pressure.
Two product terms needed to be calculated, these were
the log-transformed time since onset of symptoms x ST
elevation and log-transformed time since onset of symp-
toms squared x ST elevation. The percentage of missing
data was assessed and missing observations were multiply
imputed (m = 5) where necessary. We used partial mean
matching for the continuous variables, and logistic regres-
sion for the binary variables for the imputation, based on
all variables in the dataset. When all variables were in the
correct form, the shrinked regression coefficients of the
prediction model were applied to the data of all pa-
tients in the study, resulting in an estimated probability
of ACS for each individual. The final predicted prob-
abilities were calculated as arithmetic mean of the five
imputations. These probabilities are summarized with me-
dian and range. We dichotomized the predicted probabil-
ities with a cut-off at <2% as a rule-out criterion for ACS
according to MacGougan et al. [5]. We present the results
of the binary diagnostic rule for ACS with respect to its
sensitivity and specificity, positive and negative predictive
values, and positive and negative likelihood ratios. All ana-
lyses were performed with R statistical software for win-
dows [6].
Results
Within 18 months 186 patients agreed to participate in
the study. The median age of patients was 52 years (IQR
35-67), 130 (70%) of patients had male gender. In 168
(90%) patients the chief complaint was acute chest pain,
and in 18 (10%) it was acute dyspnea, in 49 (26%) pa-
tients both symptoms were present at presentation in
the emergency room (ER). In 42 patients troponin levels
were elevated at the initial exam. Not myocardial ische-
mia only but infections, atrial fibrillation, heart failure,
pulmonary embolism and other illnesses can cause an
increase of troponin. So the number of patients with in-
creased troponin levels is higher than the number of pa-
tients with myocardial ischemia. Further details about
patient characteristics are shown in Table 1.
In 31 (17%) patients an ACS was diagnosed, all of them
have been hospitalized. In the two weeks after attending
the emergency room in no further patient an ACS oc-
curred. In eleven of the predictor variables of the predic-
tion model there was a small percentage of missing values
(range 1% to 9% of observations, median = 3%). The miss-
ing values were multiply imputed and the calculated prob-
abilities of an ACS ranged from 0 to 1, median probability
was 0.20 (IQR: 0.05-0.46). The calculated probabilities for
more than one third of patients (36%) were less than 10%.
The distribution of calculated versus observed probabil-
ities is shown in Figure 1.
Of particular interest is the performance of the predic-
tion rule when the calculated probabilities for ACS are
below 2% (Figure 2). Two percent probability of pres-
ence of ACS seems to be the rule-out threshold for phy-
sicians without further testing [5]. In 31 (17%) patients
the calculated probability was less than 2% and four of
them actually had an ACS resulting in a sensitivity of
87%, with 95% confidence interval (CI) 70%-96% and a
specificity of 17%, 95% CI 12%-24% (Table 2). The posi-
tive predictive value (PPV) is 0.17 (95% CI 0.15-0.19)
and the negative predictive value (NPV) is 0.88 (95% CI
0.73-0.95). The positive likelihood ratio LR + = 1.04 and
the negative likelihood ratio LR- = 0.76. Further investiga-
tion in the four patients with ACS but predicted probabil-
ity below 2% of it led to the finding that three patients had
extraordinary long times since onset of symptoms: the
values were 24 hours, 48 hours and 96 hours, respectively.
The range of time since onset of symptoms was 1-9 hours
in the vignettes used to derive the probability function.
The fourth patient had an extremely large number of pack
years smoked, which was 180 and for that reason also far
outside of the range of values in the original developmen-
tal set of vignettes.
Discussion
In a sample of patients in emergency rooms with chest
pain and/or dyspnea the calculated probabilities, based
on the diagnostic probability function, in general, over-
estimate the presence of ACS. In the intermediate prob-
ability range a certain degree of imprecision is without
any negative consequences for the patient anyway be-
cause further tests to either rule-in or rule-out of ACS
will be done. Relevant is a high accuracy in the extreme
probability ranges to securely rule-out or rule-in ACS.
From a clinician’s point of view a diagnostic aid to reli-
ably rule out ACS would be of great help, because the
majority of patients with chest pain and/or dyspnea do
not have ACS. Desirable, according to a survey among
physicians in Canada, would be a diagnostic aid that cor-
rectly identifies patients with a probability of ACS of less
than two percent [5]. The threshold is that low because
missing an ACS could be life threatening for the patient
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and delayed treatment might have a negative effect on
the future course of the illness. Our study differs from
other validation studies in two aspects. Firstly, the ori-
ginal derivation study is based on a prediction model de-
rived from expect knowledge rather than from patient
data. Secondly the derivation study aimed at generating
a rule-out criterion for ACS.
In about every fifth participant of our study the calcu-
lated probabilities were less than two percent. In four of
these 31 patients an ACS was present. A detailed assess-
ment of the patient characteristics revealed that all of
the four patients were rather different with respect to
two predictor variables compared to those from which
the diagnostic probability has been derived. In the deriv-
ation sample the time since onset of symptoms ranged
from one to nine hours, and in three patients of the val-
idation sample the time since onset was more than
24 hours, in the extreme case 4 days. In the derivation
sample the number of pack-years ranged from 0 to 40
pack-years and the patient of the validation sample
smoked 180 pack-years. The estimated effect of the
predictors in the risk model is strongly dependent on
the predictors’ ranges in the derivation sample. For that
reason one would expect to obtain less precise results if
the validation sample differs from the derivation sample.
A solution for this problem could be to update the original
prediction model to include patients with longer duration
of symptoms and larger number of pack-years [7].
Comparison to literature
Pozen et al. [8] were the first to develop a diagnostic aid to
calculate the patient’s probability of a myocardial infarction
in a patient with acute chest pain. Since then further in-
struments have been developed and validated in different
patient populations [9]. Among those validation studies of
diagnostic instruments for ruling out ACS, sensitivity var-
ied between 40 and 99%, whereas the range for specificity
was 4 to 90%. The diagnostic aid with the highest value for
securely ruling-out was developed by Selker et al. [10]. The
derivation study that we intended to validate differs from
other published prediction rules as it is intended to be used
as a rule-out criterion. Therefore a direct comparison of
our results with other published prediction rules is impos-
sible since no other study applied a cut-off value as low as
2% predicted probability.
Table 1 Characteristics of included patients with medical history, signs, symptoms, ECG and lab results
Patient characteristics Median/number IQR/%
Time since onset of symptoms (h) Median: 5 IQR: 2-30
Duration of symptoms (min) Median: 180 IQR: 75-780
Acute dyspnea 67 36%
Acute chest pain 168 90%
Radiating chest pain 75 40%
Prior angina and acute episode provoked
by lesser exertion and/or lasting longer
44 24%
Age (years) Median: 52 IQR: 35-67
Male gender 130 70%
Body Mass Index in kg/m2 Median: 25.1 IQR: 22.4-28.4
Hypertension 83 45%
Smoking, number of cigarettes per
day in month prior to episode
Median: 0 IQR: 0-5
Smoking, number of pack years Median: 0 IQR: 0-11.5
Hypercholesterolemia 52 28%
Diabetes mellitus 24 13%
Peripheral vascular disease 9 5%
Stroke in personal history 2 1%
Myocardial infarction in personal history 35 19%
Heart rate (beats/minute) Median: 70 IQR: 62-83
Mean blood pressure* Median: 108.5 IQR: 99.9-118.5
ST elevation/depression ≥1 mV 20 11%
Hyperacute T wave 8 4%
Elevated troponin level 42 23%
*Mean blood pressure:= mean between systolic and diastolic blood pressure.
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Limitations and strengths
We have to point out some limitations of this study.
First, patients were probably not enrolled consecutively
and it might be that patients with a high suspicion of
ACS were more likely to be included. Supporting evi-
dence for this assumption is the fact that the prevalence
for ACS was 17% in the sample, a number that is in the
range of other studies [9]. A further limitation of our
prediction rule may be that a relatively large number of
variables is needed, and with a computer calculating the
predicted probabilities of ACS. In the age of electronic
patient charts and clinical information systems the infor-
mation should be easy to extract and the calculations
will be straightforward.
A strength of the study is that in all patients at least
one further ECG and blood exam was performed within
three to six hours after the first examination. All patients
without diagnosis of ACS in the emergency room were
contacted and interviewed by telephone ten to fourteen
days after a visit of the emergency room. We cannot ex-
clude that patients were diagnosed with cardiovascular
disease later. However, the current study focused on the
Figure 1 Calibration plot showing observed versus predicted probabilities for ACS.
Patients with acute chest
pain/dyspena n = 186 
Calculated probability of ACS < 2%
n= 31
Calculated probability of
n= 155
ACS n = 4 No ACS n = 27 No ACS n = 128ACS n = 27
Figure 2 Patient flow chart. (ACS = Acute Coronary Syndrome).
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safety of emergency department assessment for acute cor-
onary syndrome.
Clinical implications
Even though only a minority of patients with chest pain
has ACS or other life-threatening diseases, clinicians in
the emergency room are cautious when making decisions
about patients with chest pain. Cumulative data from the
Physicians Insurers Association of America from 1985 to
2010 indicate that in emergency medicine chest pain is
among the most prevalent and most expensive conditions
for malpractice claims in the United States [11]. As a con-
sequence, clinicians initiate diagnostic testing for ACS at
very low threshold levels. Current evaluation strategies
typically require clinical observation for several hours, ser-
ial electrocardiograms and biomarker measurements and
eventually some form of functional testing to exclude
myocardial ischemia. As emergency room clinicians are
under considerable pressure to reduce resource use with-
out increasing the probability of adverse outcomes in pa-
tients with chest pain a reliable instrument to rule out
ACS after a first examination would be of great value.
Future research
It appears that the domain of the derivation study was
drawn too narrow for some of the patients with acute on-
set of chest pain and/or dyspnea. The estimated coeffi-
cients for duration of symptoms and number of pack years
cannot be extrapolated to values far outside the range of
the original vignettes. Therefore future research should
address the question of how to derive a new or updated
diagnostic probability function with wider ranges of con-
tinuous predictors. After that, the new probability function
should be validated in a consecutive sample of patients.
The results of our study also have implications for the
derivation of new prediction rules in other clinical appli-
cations based on expert knowledge. As described above,
we found that our rule performed less than optimal if
continuous predictors were far outside the original range
of values. If broad ranges of values in the derivation
study do not seem reasonable in the first place, future
studies should include some kind of sensitivity analysis
for the rule’s out-of-sample prediction performance.
Conclusion
The proposed probability function, with a 2% cut-off for
ruling out ACS works quite well if the patient data lie
within the ranges of values of the original vignettes. If the
observations deviate too much from these ranges, the pre-
dicted probabilities for ACS should be seen with caution.
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